Outcomes and Prognostic Factors In African American / Black Patients With Mycosis Fungoides And Sézary Syndrome: Retrospective Analysis Of 157 Patients From A Referral Cancer Center.
The prevalence of mycosis fungoides / Sézary syndrome (MF/SS) is higher in the African American (AA)/black population compared to Caucasians in the United States and worse outcomes have been observed in AA/black patients. To describe the outcomes and to identify prognostic factors in AA/black patients with MF/SS. Clinical features and follow-up data were analyzed in 157 self-identified AA/black patients seen between 1994-2018. We included 122 patients with early-stage MF and 35 patients with advanced-stage disease (median follow-up of 25 months). >80% of the patients who died from disease or progressed presented with erythema/hyperpigmentation without hypopigmentation. Patients presenting with hypopigmentation, either as the sole manifestation or in combination with other lesions, had better overall survival (P=.002) and progression free survival (P=.014). Clinical stage, TNMB classification, plaque disease and elevated serum lactate dehydrogenase were also significantly associated with outcomes. Demographic and socioeconomic parameters were not associated with prognosis. A retrospective study at a single cancer center. MF/SS manifestations and outcomes in AA/black patients are heterogenous. Demographic and socioeconomic factors do not seem to have a prognostic role, while clinical characteristics may help to stratify for risk of progression and shorter survival, allowing for individually-tailored therapeutic interventions.